Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, PPJ Healthcare Enterprises's enterprise value is $0.45 Mil.
PPJ Healthcare Enterprises's EBITDA for the trailing twelve months (TTM) ended in Dec. 2009 was $0.12 Mil. Therefore, PPJ Healthcare Enterprises's EV-to-EBITDA for today is 3.59.
The historical rank and industry rank for PPJ Healthcare Enterprises's EV-to-EBITDA or its related term are showing as below:
PPJE's EV-to-EBITDA is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 10.705 * Ranked among companies with meaningful EV-to-EBITDA only.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
PPJ Healthcare Enterprises's PE Ratio (TTM) for today is calculated as:
PPJ Healthcare Enterprises's share price for today is $5.0E-5.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. PPJ Healthcare Enterprises's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2009 was $0.000.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, PPJ Healthcare Enterprises's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PPJ Healthcare Enterprises EV-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, PPJ Healthcare Enterprises's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where PPJ Healthcare Enterprises's EV-to-EBITDA falls into.
PPJ Healthcare Enterprises's current Enterprise Value is $0.45 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. PPJ Healthcare Enterprises's EBITDA for the trailing twelve months (TTM) ended in Dec. 2009 was $0.12 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PPJ Healthcare Enterprises (PPJE) has a EV-to-EBITDA of 3.59 as of Aug. 24, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on PPJ Healthcare Enterprises.
Is PPJ Healthcare Enterprises' EV-to-EBITDA too high?
PPJ Healthcare Enterprises' current EV-to-EBITDA is 3.59. The Healthcare Providers & Services industry median EV-to-EBITDA is 10.71. PPJ Healthcare Enterprises' value of 3.59 is 66.5% below this industry median.
How does PPJ Healthcare Enterprises' EV-to-EBITDA compare to LOGQ and MDFI?
PPJ Healthcare Enterprises' EV-to-EBITDA of 3.59 can be compared against companies in the Healthcare Providers & Services industry. The industry median EV-to-EBITDA is 10.71. PPJ Healthcare Enterprises' value of 3.59 is 66.5% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Healthcare Providers & Services company?
The median EV-to-EBITDA among Healthcare Providers & Services companies is 10.71, based on 516 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PPJ Healthcare Enterprises's current EV-to-EBITDA of 3.59 is 66.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on PPJ Healthcare Enterprises. For the Healthcare Providers & Services industry, the median EV-to-EBITDA is 10.71 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PPJ Healthcare Enterprises's current EV-to-EBITDA is 3.59. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PPJ Healthcare Enterprises stock overvalued right now?
PPJ Healthcare Enterprises (PPJE) has a current EV-to-EBITDA of 3.59. The current EV-to-EBITDA is 3.59 and 66.5% below the Healthcare Providers & Services industry median of 10.71. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For PPJ Healthcare Enterprises (PPJE), the current EV-to-EBITDA is 3.59 as of Aug. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
PPJ Healthcare Enterprises Inc engages in joint venturing with doctors in setting up new practices, marketing, and management of pain management practices and blood culture labs. The company also engages in the development and testing of medical marijuana, medical cannabis products, and medical billing specialties in anesthesiology. The projects of the company include automated biller, medical billing service, pain management center, and Lab testing.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PPJE has been successfully added to your 
